Don’t forget to renew your RCR membership by 1 June 2023

  1. Home
  2. Clinical oncology
  3. Clinical oncology publications

Clinical oncology publications

The RCR produces a range of publications including standards for the delivery of high-quality oncology services, guidance on good practice and workforce reports. Electronic copies of the majority of our publications are available to download free of charge.

Publications are reviewed regularly by the Clinical Oncology Professional Support and Standards Board to ensure that they remain relevant and up to date.

If you need further help please contact us by emailing: publications@rcr.ac.uk.

 

 

Clinical Oncology Publications

Related content

Find Documents

5073830jpg

Bladder cancer – RCR consensus statements -

Status: 
Current
Please note : Radiotherapy Dose Fractionation Third Edition and Timely Delivery of Radical Radiotherapy: guidelines for the management of unscheduled treatment interruptions, fourth edition are both currently under review and due to be published later in 2023. You should therefore refer to the Bladder Consensus Statements for the latest guidance on radical and palliative fractionation schedules for bladder cancer, and how treatment interruptions should be managed in the bladder cancer patient (i.e. bladder cancer should be treated as a Category 1 tumour). The RCR consensus process was...
4884980jpg

Recommendations for using radiotherapy for benign disease in the UK -

Status: 
Current
This guidance is intended as a useful resource for clinical oncologists who receive referrals for patients with benign conditions.
4443820jpg

Radiotherapy target volume definition and peer review, second edition – RCR guidance -

Status: 
Current
Target volume definition requires an assessment of clinical information and imaging to know the location of the tumour (or tumour bed in the case of adjuvant treatment), an understanding of the possible routes of microscopic spread and an appreciation of potential positional errors. The uncertainties involved in this complex decision-making process mean that the oncologist must use judgement to consider the potential benefits and possible harms of treatment for each individual case. Wherever complex human judgements are made there is the potential for variability, bias and error. The Royal...
4854550jpg

Clinical oncology job planning guidance for consultant and SAS doctors 2022 -

Status: 
Current
Workforce pressures in clinical oncology (CO) have continued to grow since the publication of the third edition of the guide to job planning in CO in 2015. More clinical oncologists are retiring early, more are working less than full time (LTFT) and the Covid-19 pandemic has changed the workplace forever. In this context, the job planning process is more important than ever to ensure hospitals support a workforce that is able to deliver the excellent clinical care to which we all aspire. This fourth edition is therefore a complete update to the previous guidance. It includes clear direction...
5001100jpg

Ten top tips for writing an outpatient letter - BFCO(19)8

Status: 
Current
Ten tips to bear in mind when writing outpatient letters
3794210jpg

Head and neck cancer - RCR consensus statements - BFCO(22)1

Status: 
Current
The head and neck cancer consensus statements should serve as a practical stimulus for head and neck cancer teams to review their current radiotherapy service to ensure that they are able to deliver optimal treatment for their patients. They should be adopted in parallel with relevant National Institute for Health and Care Excellence (NICE) guidance.
4982380jpg

Review of molecular radiotherapy services in the UK - RCR(21)$

Status: 
Current
This document provides the four nations with a comprehensive, pragmatic blueprint to allow the development of molecular radiotherapy services in preparation for the new agents which are soon to arrive.
5001280jpg

Incidental irradiation of the spleen - RCR guidance - BFCO(21)9

Status: 
Current
The purpose of this guidance is to raise awareness of the spleen as an organ at risk (OAR) structure and to ensure that, for all patients receiving radiotherapy to the spleen, the risk of resultant functional hyposplenism is assessed and decisions on appropriate management are made if required.
5000590jpg

Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements - BFCO(21)1

Status: 
Current
The Royal College of Radiologist’s (RCR) 2016 breast consensus statements made recommendations on hypofractionation. There was consensus, with strong support, that there was no indication to use more than 15 fractions for the breast, chest wall or nodal areas. Following the FAST-Forward trial primary endpoint publication, the following statements were agreed in 2020 are intended to supplement the 2016 statements. The new statements for postoperative radiotherapy for breast cancer hypofraction are: Consensus statement 1: Offer 26 Gray (Gy) in five fractions over one week for whole breast...
4932220jpg

National rectal cancer intensity-modulated radiotherapy (IMRT) guidance - BFCO(21)1

Status: 
Current
With the use of intensity-modulated radiotherapy (IMRT) for rectal cancer increasing globally, the RCR will shortly be publishing guidance for the use of IMRT/VMAT radiotherapy for rectal cancer in the UK. Register your interest in the upcoming guidance.

Current clinical oncology guidance projects

We’re committed to developing a wide range of guidance that supports good practice in oncology and service delivery – and reflects the changing healthcare landscape.

Endorsement

Permissions

Apply for permission to use RCR copyrighted material

RCR Endorsed Documents